immunotherapy

Preliminary results released of Phase 1 clinical trial targeting mesothelin

Yesterday, at the annual meeting of the American Society of Gene and Cell Therapy in Chicago, researchers from Memorial Sloan Kettering Cancer Center released a preliminary report on their Phase 1 study into regionally delivered autologous mesothelin-targeted CAR T cells in patients with pleural mesothelioma.
Drs. Prasad Adusumilli, with co-authors Marjorie Zauderer, and Valerie Rusch (all […]



Mesothelioma Researcher Authors Journal Article on CAR T-cell Therapy

Mesothelioma researcher and Meso Foundation grant recipient Prasad S. Adusumilli, MD, FACS, FCCP, of the Memorial Sloan Kettering Cancer Center (MSKCC) was an author on the review article CAR T-cell therapy for lung cancer and malignant pleural mesothelioma recently published in Translational Research: The Journal of Laboratory and Clinical Medicine.
Dr. Adusumilli is a thoracic surgeon-scientist […]



BREAKING NEWS FROM ASCO: Promising Results Released from Mesothelioma Clinical Trial

This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results of the IFCT-1501 MAPS-2 clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting. The study was sponsored by the French Cooperative Thoracic Intergroup (IFCT) with drugs and […]